A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection

Kidney International

Volumn 81, Issue 2, 2012, Pages 207-219

  Thaunat, Olivier ^a,b,c   Graff Dubois, Stephanie ^c,d   Fabien, Nicole ^b,c,e   Duthey, Aurelie ^c   Attuil Audenis, Valerie ^c   Nicoletti, Antonino ^c   Patey, Natcha ^f   Morelon, Emmanuel ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

autoimmunity; BAFF; chronic rejection; IL 17; tertiary lymphoid tissue; Treg

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; B CELL ACTIVATING FACTOR; CD134 ANTIGEN; KIDNEY ANTIGEN;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KIDNEY ALLOGRAFT; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL;

EID: 84855204739     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.317     Document Type: Article

References (55)

1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289-1295. (Pubitemid 39013575)
2. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004; 351: 2761-2766. (Pubitemid 39665333)
3. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665-673. (Pubitemid 36745238)
4. Terasaki P, Mizutani K. Antibody mediated rejection: update 2006. Clin J Am Soc Nephrol 2006; 1: 400-403.
5. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056. (Pubitemid 46536891)
6. Vongwiwatana A, Tasanarong A, Hidalgo LG, et al. The role of B cells and alloantibody in the host response to human organ allografts. Immunol Rev 2003; 196: 197-218. (Pubitemid 37468112)
7. Li F, Atz ME, Reed EF. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. Curr Opin Immunol 2009; 21: 557-562.
8. Thaunat O, Louedec L, Dai J, et al. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 2359-2365. (Pubitemid 44465734)
9. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570-1576. (Pubitemid 40615406)
10. Lerut E, Van Damme B, Noizat-Pirenne F, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007; 47: 28-40. (Pubitemid 46006306)
11. Joosten SA, Sijpkens YW, van Ham V, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005; 5: 383-393. (Pubitemid 40179526)
12. Thaunat O, Field AC, Dai J, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005; 102: 14723-14728. (Pubitemid 41457123)
13. Thaunat O, Nicoletti A. Lymphoid neogenesis in chronic rejection. Curr Opin Organ Transplant 2008; 13: 16-19.
14. Thaunat O, Patey N, Morelon E, et al. Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr Opin Immunol 2006; 18: 576-579. (Pubitemid 44311452)
15. Baddoura FK, Nasr IW, Wrobel B, et al. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005; 5: 510-516. (Pubitemid 40313342)
16. Kerjaschki D, Regele HM, Moosberger I, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612. (Pubitemid 38294790)
17. Kratz A, Campos-Neto A, Hanson MS, et al. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-1472. (Pubitemid 26134289)
18. Thaunat O, Patey N, Caligiuri G, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 2010; 185: 717-728.
19. Ruggiero R, Fietsam Jr R, Thomas GA, et al. Detection of canine allograft lung rejection by pulmonary lymphoscintigraphy. J Thorac Cardiovasc Surg 1994; 108: 253-258. (Pubitemid 24258664)
20. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol 2006; 27: 441-445. (Pubitemid 44354310)
21. Le Pottier L, Devauchelle V, Fautrel A, et al. Ectopic germinal centers are rare in Sjogren?s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009; 182: 3540-3547.
22. Weyand CM, Kurtin PJ, Goronzy JJ. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol 2001; 159: 787-793. (Pubitemid 32847167)
23. Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 2010; 90: 113-120.
24. Dubel L, Farges O, Johanet C, et al. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998; 65: 1072-1075. (Pubitemid 28208426)
25. Fedoseyeva EV, Zhang F, Orr PL, et al. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 6836-6842. (Pubitemid 29309412)
26. Goers TA, Ramachandran S, Aloush A, et al. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008; 180: 4487-4494.
27. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886-892. (Pubitemid 32417348)
28. Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-324. (Pubitemid 34823674)
29. Keren D. Autoimmune disease. In: Wild D (ed). The Immunoassay Handbook, 3rd edn, Oxford: Elsevier, 2005, pp 712-724.
30. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
31. Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cellactivating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009; 10: 778-785.
32. Ettinger R, Kuchen S, Lipsky PE. The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev 2008; 223: 60-86. (Pubitemid 351986176)
33. Thaunat O, Graff-Dubois S, Brouard S, et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PloS One 2010; 5: e11398.
34. Dai Z, Li Q, Wang Y, et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310-317. (Pubitemid 38544215)
35. Yang J, Brook MO, Carvalho-Gaspar M, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007; 104: 19954-19959.
36. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 2010; 28: 57-78.
37. Thaunat O, Patey N, Gautreau C, et al. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 2008; 85: 1648-1653.
38. Deteix C, Attuil-Audenis V, Duthey A, et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184: 5344-5351.
39. Wehner JR, Fox-Talbot K, Halushka MK, et al. B cells and plasma cells in coronaries of chronically rejected cardiac transplants. Transplantation 2010; 89: 1141-1148.
40. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008; 74: 664-673.
41. Li L, Wadia P, Chen R, et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and ?antibodyome? measures. Proc Natl Acad Sci USA 2009; 106: 4148-4153.
42. Porcheray F, DeVito J, Yeap BY, et al. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239-1246.
43. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996; 93: 2264-2271. (Pubitemid 26104339)
44. Melchers F. Anergic B cells caught in the act. Immunity 2006; 25: 864-867. (Pubitemid 44894951)
45. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science (New York, NY) 2003; 301: 1374-1377. (Pubitemid 37075812)
46. Samuels J, Ng YS, Coupillaud C, et al. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005; 201: 1659-1667. (Pubitemid 40721009)
47. Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009; 6: e1.
48. Schroder AE, Greiner A, Seyfert C, et al. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996; 93: 221-225. (Pubitemid 26038131)
49. Sater RA, Sandel PC, Monroe JG. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 1998; 10: 1673-1682. (Pubitemid 28502381)
50. Herber D, Brown TP, Liang S, et al. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R. Fc reduces disease progression. J Immunol 2007; 178: 3822-3830. (Pubitemid 46417651)
51. Hsu HC, Yang P, Wang J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-175.
52. Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science (New York, NY) 2001; 293: 2111-2114. (Pubitemid 32848063)
53. Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigenengaged B cells due to increased dependence on BAFF. Immunity 2004; 20: 441-453. (Pubitemid 38482122)
54. Thien M, Phan TG, Gardam S, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004; 20: 785-798. (Pubitemid 38757447)
55. Murata K, Nose M, Ndhlovu LC, et al. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases. J Immunol 2002; 169: 4628-4636. (Pubitemid 35178243)